When a baby under 24 months old struggles to breathe due to bronchiolitis, doctors must decide on the best way to deliver oxygen. One common method is high-flow nasal cannula (HFNC), which provides a steady stream of oxygen through a mask or tube. This study looked at how HFNC compares to other standard treatments like low-flow nasal cannula and CPAP.
The analysis of over 4,000 children found that while HFNC did not reduce the need for mechanical ventilation compared to either low-flow options or CPAP, it did offer some specific benefits. Specifically, babies receiving HFNC instead of low-flow systems had a lower rate of treatment failure and spent less time in the pediatric intensive care unit (PICU). They also required shorter total oxygen therapy durations when compared to low-flow methods.
It is important to note that these results are mixed. While HFNC helped reduce some complications and hospital stay times, it did not show a significant difference over CPAP for many outcomes. Because the evidence is nuanced, doctors may consider HFNC as an initial treatment option, especially when a child needs more support than a standard low-flow system can provide.
